Introduction of disulfide bonds into proteins entering the secretory pathway is catalyzed by Ero1p, which generates disulfide bonds de novo, and Pdi1p, which transfers disulfides to substrate proteins. A sufficiently oxidizing environment must be maintained in the endoplasmic reticulum (ER) to allow for disulfide formation, but a pool of reduced thiols is needed for isomerization of incorrectly paired disulfides. We have found that hyperoxidation of the ER is prevented by attenuation of Ero1p activity through noncatalytic cysteine pairs. Deregulated Ero1p mutants lacking certain cysteines show increased enzyme activity, a decreased lag phase in kinetic assays, and growth defects in vivo. We hypothesize that noncatalytic cysteine pairs in Ero1p sense the level of potential substrates in the ER and correspondingly modulate Ero1p activity as part of a homeostatic regulatory system governing the thiol-disulfide balance in the ER.
INTRODUCTION
The capacity to introduce disulfide bonds into proteins that pass through the endoplasmic reticulum (ER) is required for viability of the cell. Proteins undergoing oxidative folding obtain disulfides by dithiol-disulfide exchange with the oxidized form of the thioredoxin-like protein Pdi1p (Frand and Kaiser, 1999) . Reduced Pdi1p is restored to an oxidized state by dithiol-disulfide exchange with the membrane-associated flavoprotein Ero1p (Frand and Kaiser, 1999) , which in turn is oxidized by electron transfer to nonthiol electron acceptors such as oxygen (Gross et al., 2004 (Gross et al., , 2006 Tu et al., 2000; Tu and Weissman, 2002) . Both PDI1 and ERO1 are essential genes in yeast. A conditional ero1-1 mutant fails to support disulfide formation in the ER and leads to the accumulation of misfolded proteins (Frand and Kaiser, 1998) .
Coexisting with the pathway for disulfide formation in the ER lumen is a competing pathway for disulfide reduction based on reduced glutathione (reviewed in Chakravarthi et al. [2006] ). Glutathione is a tripeptide (L-g-glutamyl-L-cysteinyl-glycine) synthesized in the cytosol yet localized throughout the cell. Disruption of glutathione synthesis (by deletion of GSH1, encoding the catalyst of the first step in glutathione synthesis) restores viability to an ero1-1 yeast strain with a defective protein oxidation system, suggesting that glutathione serves as a reductant in the ER to offset the activity of Ero1p (Cuozzo and Kaiser, 1999) . Correspondingly, oxidative protein folding in yeast cells unable to synthesize glutathione is more readily compromised by addition of a small molecule oxidant (Cuozzo and Kaiser, 1999) . Mammalian cells with decreased glutathione levels accumulate nonnatively disulfide-bonded proteins, suggesting that glutathione plays a role in disulfide reduction or isomerization (Chakravarthi and Bulleid, 2004; Molteni et al., 2004) .
The oxidizing capacity of the ER can be increased or decreased by altering the levels of Ero1p or glutathione (Cuozzo and Kaiser, 1999; Frand and Kaiser, 1998; Pollard et al., 1998) . Upregulation of ERO1 and GSH1 naturally occurs in response to cellular redox stress, which provides an important yet relatively slow means of adapting to changes in the ER redox environment (Stephen et al., 1995; Takemori et al., 2006; Travers et al., 2000) . We questioned whether mechanisms exist to rapidly regulate Ero1p activity. Ero1p displays complex kinetics in assays in vitro, suggesting that modulation of Ero1p activity at the protein level can occur (Gross et al., 2004; Gross et al., 2006) . The flexibility of various regions within the Ero1p structure further suggests the potential for conformational changes that may affect catalytic activity (Gross et al., 2004) .
Ero1p is a large flavoenzyme with a ten-helix core covered by a $100 residue cap largely devoid of secondary structure (Gross et al., 2004) . Yeast Ero1p contains 14 cysteines, at least ten of which are paired in disulfides within the nonhelical cap or at the interface between the cap and the core (Figures 1A and 1B) . Only four cysteines are essential for catalytic activity: Cys352-Cys355 (activesite cysteines) and Cys100-Cys105 (''shuttle'' cysteines) (Frand and Kaiser, 2000) . The catalytic activity of Ero1p involves direct oxidation of Pdi1p by the shuttle disulfide, followed by reoxidation of the reduced shuttle cysteines through internal dithiol-disulfide exchange with the active site (Frand and Kaiser, 2000; Sevier and Kaiser, 2006) . The Ero1p active site is returned to the oxidized state by transfer of electrons to molecular oxygen via the Ero1p flavin cofactor (Gross et al., 2004 (Gross et al., , 2006 Tu et al., 2000; Tu and Weissman, 2002) .
Two crystal forms of Ero1p show two distinct conformations of the polypeptide loop containing the shuttle cysteines, reflecting what is likely a range of motion for this region in solution (Gross et al., 2004) . Movement of the shuttle-cysteine loop may facilitate transfer of electrons between the redox-active cysteines in Pdi1p and the obscured active-site cysteines of Ero1p. The shuttlecysteine loop appears to restrict direct access of protein substrates to the Ero1p active site, limiting nonspecific oxidation of thiols in the ER .
Here, we consider the roles of two cysteine pairs, Cys90-Cys349 and Cys150-Cys295, that link the nonhelical Ero1p cap to the helical core of the enzyme. Our in vitro and in vivo studies show that the redox state of these cysteine pairs, which are not direct participants in the electron relay from reduced substrate to oxygen, influences Ero1p catalytic activity. We demonstrate that these cysteines sense the ER oxidation state and correspondingly modulate Ero1p activity, perhaps by influencing mobility of the loop containing the shuttle cysteines. We propose that redox regulation of Ero1p at the protein level reflects a homeostatic regulatory system that rapidly (Gross et al., 2004) . (B) Cysteine side chains are represented as green and yellow spheres. The nonhelical cap of Ero1p-c is colored according to the rainbow spectrum, starting with red (residue 75, red arrowhead) and ending with purple (residue 175, purple arrowhead). (C) Complementation of an ero1D strain by ERO1 cysteine mutants. CKY933 containing the plasmids pAF85, pCS169, pCS294, pCS430, pCS523, pCS524, or empty vector were spotted onto SMM plates with or without 5-FOA. (D) Processing of CPY in ero1D cells containing the ERO1 plasmids in (C). Cells were pulse labeled for 7 min and chased at 30 C, and CPY was immunoprecipitated and resolved by SDS-PAGE. ER (p1), Golgi (p2), and vacuolar (m) forms of CPY are indicated.
responds to redox conditions in the ER, allowing the cell to maintain a redox environment favorable for native disulfide-bond formation.
RESULTS

Cys90-Cys349 and Cys150-Cys295 Disulfides Inhibit Ero1p Activity
To assess the function of individual disulfide bonds in Ero1p, we mutated each disulfide-bonded pair of cysteines. Of the five known disulfides in Ero1p, only Cys100-Cys105 and Cys352-Cys355 are essential for Ero1p activity in vivo (Frand and Kaiser, 2000) ; Ero1p mutants with alanine residues in place of Cys90-Cys349, Cys143-Cys166, or Cys150-Cys295 are designated functional based on their ability to complement a chromosomal deletion of ERO1 ( Figures 1C and 1D ). For a more sensitive and direct assessment of Ero1p cysteine mutants, we assayed the ability of wild-type and mutant Ero1p to oxidize reduced protein substrates in vitro. For our initial experiments, we used Escherichia coli thioredoxin (Trx1), which is structurally related to physiological Ero1p substrates such as Pdi1p. Trx1 is useful for kinetic studies of Ero1p because it can be purified in high yield and is readily oxidized by Ero1p in vitro (Gross et al., 2006; Sevier and Kaiser, 2006) . Recombinant Ero1p (residues 56-424; Ero1p-c) (Gross et al., 2004) and Ero1p-c mutants lacking noncatalytic cysteine pairs (Ero1p-c-C90A-C349A, Ero1p-c-C150A-C295A, and Ero1p-c-C143A-C166A) were purified from E. coli and mixed with reduced Trx1 at a ratio of 1:200. Ero1p-c activity was assayed by monitoring consumption of oxygen (which was converted to hydrogen peroxide). Strikingly, Ero1p-c-C150A-C295A exhibited enhanced catalytic activity toward Trx1. This mutant showed a 3-fold increase in the maximal rate of oxygen consumption relative to wild-type (Figure 2A ), suggesting that formation of the Cys150-Cys295 disulfide normally inhibits Ero1p activity. The rate of oxygen consumption for Ero1p-c-C90A-C349A was similar to that observed with wild-type Ero1p-c ( Figure 2B ). Ero1p-c-C143A-C166A showed a decreased rate of oxygen consumption relative to wild-type, likely due to loss of structural stability (data not shown). When tested on Pdi1p, Ero1p-c-C150A-C295A again showed a 3-fold increase in the maximal rate of oxygen consumption relative to wild-type Ero1p ( Figure 2C ). Consistent with the higher redox potential of Pdi1p relative to Trx1 (Lundstrom and Holmgren, 1993) , Ero1p-c oxidized Pdi1p much more slowly than Trx1 (Figure 2) .
When oxygen consumption during catalysis of disulfide bond formation by Ero1p-c was monitored, a pronounced lag phase was observed (Figure 2 ; Gross et al., 2006) . This lag, seen with all reducing substrates studied to date, appears to reflect an activation step required to initiate Ero1p-c catalytic activity. Notably, the $1.5 min lag seen in our assays with Trx1 and wild-type Ero1p-c was shortened to about 10 s for Ero1p-c-C150A-C295A (Figure 2A , inset). Ero1p-c-C90A-C349A showed a more modest decrease in the lag to $1 min ( Figure 2B , inset). These results suggest that the lag in oxygen consumption observed with wild-type Ero1p-c reflects the reduction of inhibitory Cys150-Cys295 and Cys90-Cys349 disulfides. The activation of Ero1p is likely accomplished in vitro by electron transfer from reduced Trx1 to Cys150-Cys295 and Cys90-Cys349. Oxygen consumption by Ero1p-c during reaction with reduced Trx1 was measured. Enzyme was added at time 0. Graph insets show an expanded view of the lag phase for wild-type Ero1p-c, which is decreased for Ero1p-c-C90A-C349A (B) and virtually absent with Ero1p-c-C150A-C295A (A). (C) Oxygen consumption during oxidation of Pdi1p in the presence of reduced glutathione (GSH) was measured after injection of Ero1p. GSH does not serve as a direct substrate of Ero1p (note black and orange traces) and was added to increase the amplitude of the reaction by rereducing Pdi1p.
Successive Disulfide Reduction Precedes Ero1p Activation
To examine the redox state of Ero1p during and after the lag in oxygen consumption, aliquots were removed from the oxygen electrode chamber as the reaction between Ero1p and Trx1 proceeded, and free thiols were alkylated with 4-acetamido-4 0 -maleimidylstilbene-2,2 0 -disulfonic acid (AMS). Oxidation of reduced Trx1 during the reaction with Ero1p-c was confirmed by an increase in electrophoretic mobility of Trx1 over time ( Figure 3B ). As anticipated, Ero1p-c also underwent redox changes during reaction with Trx1. Prior to substrate addition, Ero1p-c was fully oxidized and migrated rapidly in the gel. Within 20 s of substrate addition, a mobility shift in Ero1p-c indicated opening of at least one disulfide ( Figure 3B ). This slowly migrating Ero1p-c species was detected throughout the lag phase, and after about 1 min, an even slower species appeared. These reduced forms of Ero1p-c persisted until all the substrate had been oxidized, when Ero1p-c returned to its compact, disulfide-bonded form.
The number of added AMS moieties affects the rate of migration of reduced Ero1p-c species, but under nonreducing conditions, migration of partially reduced Ero1p-c also depends on the distance in primary structure between cysteines involved in disulfides. Reduction of disulfide bonds linking cysteines far apart in sequence (''long-range disulfides''), such as Cys90-Cys349 and Cys150-Cys295 ( Figure 1A) , will cause the greatest increase in hydrodynamic radius of the SDS-bound Ero1p-c species and thus the greatest decrease in mobility. The reduction of closely spaced cysteines involved in disulfide bonds (Cys100-Cys105, Cys143-Cys166, or Cys352-Cys355) will have a correspondingly smaller effect on mobility. Using migration of Cys-to-Ala mutants as standards, we correlated the reduced forms of Ero1p-c observed during our kinetic assays with specific disulfide reduction. The first reduced Ero1p-c species (observed 20 s after Trx1 addition) comigrated with an Ero1p-c mutant lacking Cys150-Cys295, suggesting that the initial step of Ero1p activation was Cys150-Cys295 reduction (Figure 3B) . The more slowly migrating reduced species (appearing after 1 min) likely reflects reduction of both Cys150-Cys295 and Cys90-Cys349, because this band migrated more slowly than both Ero1p-c-C150A-C295A and Ero1p-c-C90A-C349A ( Figure 3B ). The absence of a band comigrating with Ero1p-c-C90A-C349A suggests that a species corresponding to reduction of Cys90-Cys349 alone did not occur. Instead, reduction of Ero1p appeared to take place in two steps, with reduction of Cys150-Cys295 followed by reduction of Cys90-Cys349. Some of the reduced species appeared as doublets, which most likely reflects the presence or absence of a short-range disulfide. To confirm long-range and probe for short-range disulfide reduction in activated Ero1p-c, Ero1p-c was incubated with reduced Trx1, blocked postlag by N-ethylmaleimide (NEM), and analyzed by liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS). At least partial NEM labeling was detected for the following cysteines: Cys90, Cys143, Cys150, Cys166, Cys295, and Cys349 (data not shown).
Analysis of Ero1p mutants unable to form one of the two long-range disulfides, Ero1p-c-C90A-C349A and Ero1p-c-C150A-C295A, confirmed that reduction of both Cys150-Cys295 and Cys90-Cys349 precedes Ero1p activation. Both Ero1p-c-C90A-C349A and Ero1p-c-C150A-C295A underwent significant migration shifts to a more reduced form after exposure to reduced Trx1 ( Figure 3C ). Reduction of the remaining long-range disulfide in these mutants preceded the accumulation of oxidized Trx1 ( Figure 3C ). Reduction of both long-range disulfides in Ero1p-c-C100A-C105A, a mutant lacking the catalytic shuttle cysteines, occurred with similar kinetics to wildtype Ero1p, indicating that activation does not depend on Ero1p activity ( Figure 3C ).
Although both Ero1p-c-C90A-C349A and Ero1p-c-C150A-C295A were rapidly reduced upon exposure to reduced Trx1, Ero1p-c-C90A-C349A showed a delay in the production of oxidized Trx1 compared to Ero1p-c-C150A-C295A ( Figure 3C ). This delay could reflect the time required to achieve an additional conformational change necessary for Ero1p activation. Rapid reduction of Cys90-Cys349 in the Ero1p-c-C150A-C295A mutant (Figure 3C) , relative to the delayed reduction of Cys90-Cys349 in wild-type Ero1p ( Figure 3B ), may indicate destabilization of the Cys90-Cys349 disulfide when Cys150-Cys295 is absent or reduced. Such instability may be an inherent feature of the reductive activation process, as Cys90-Cys349 reduction in wild-type Ero1p was not observed until Cys150-Cys295 reduction had been initiated. The observation that reduction of both Cys90-Cys349 and Cys150-Cys295 precedes Ero1p activation suggests that these disulfides are ''regulatory'' bonds.
Ero1p-c lacking both Cys150-Cys295 and Cys90-Cys349 was insoluble when expressed in E. coli and could not be purified for use in our in vitro assays (data not shown). The correlation between inability to form both disulfides and insolubility suggests that large structural perturbations occur when these disulfides are absent. To confirm that reduction of Cys90-Cys349 and Cys150-Cys295 promotes rather than compromises enzyme activity, we took advantage of an observation that trypsin cleaves Ero1p-c uniquely after Lys154 to produce a catalytically active species comprised of two fragments ($17 and $30 kDa) linked by all three noncatalytic disulfides: Cys90-Cys349, Cys150-Cys295, and Cys143-Cys166. Transient, simultaneous reduction of all three disulfides during catalysis of Trx1 oxidation by trypsin-cleaved Ero1p-c was evident by dissociation of the cleavage fragments during the reaction ( Figure 3D ). Partial Ero1p-c reduction early after Trx1 addition (asterisk) and reoxidation late in the reaction (ox.) were also detected ( Figure 3D ).
Ero1p Is Inactivated after Consumption of Substrate
In our in vitro kinetic assays, oxygen (>250 mM) was present in excess of reduced Trx1 (100 mM), allowing for continual regeneration of the Ero1p active site and complete oxidation of Trx1. Reoxidation of the regulatory disulfides in wild-type Ero1p-c and the Ero1p-c mutants, Ero1p-c-C90A-C349A and Ero1p-c-C150A-C295A, was apparent after most of the Trx1 became oxidized in each case ( Figures 3B and 3C ). Ero1p-c-C100A-C105A remained in the reduced form after 20 min, consistent with its limited ability to catalyze Trx1 oxidation ( Figure 3C ).
To test whether reoxidation of Ero1p after substrate consumption inactivates Ero1p, we allowed recombinant Ero1p (residues 10-424) to completely oxidize reduced Trx1 and then, after various delay times, added a second aliquot of reduced Trx1 ( Figure 3E ). When the second aliquot was added shortly after complete oxidation of the first, oxidation of the second aliquot proceeded without a lag. However, as the time between the first and second aliquots increased, the length of the second lag phase increased. Approximately 10 min were required between aliquots to fully restore the lag phase, which likely reflects the time required for complete reoxidation of Ero1p. Notably, wild-type Ero1p that has already overcome the lag (similar to the C150A-C295A mutant) shows a $2-fold faster maximal rate of oxygen consumption relative to wild-type Ero1p that still has to overcome the lag during the course of the reaction ( Figure 3E , compare 13.8 versus 2.6 min curves), suggesting that Ero1p-C150A-C295A is accurately recapitulating the reduced, activated form wild-type Ero1p.
Reduction of Ero1p Disulfides Correlates with ER Redox Changes
To determine whether the redox potentials of Cys90-Cys349 and Cys150-Cys295 are appropriate for reductive activation of Ero1p in vivo, we followed the redox state of these disulfides under normal and relatively reducing ER conditions. To make the ER less oxidizing, we grew the temperature-sensitive ero1-1 strain at the permissive temperature of 24 C. Under these conditions, cell growth and disulfide formation occur, yet the ER has a diminished oxidative capacity, as indicated by hypersensitivity to the reducing agent dithiothreitol (DTT) (Frand and Kaiser, 1998) . To decouple Ero1p expression and ER oxidation, we used a myc-tagged catalytically inactive Ero1p-C100A-C105A to follow the redox states of Cys90-Cys349 and Cys150-Cys295.
To determine the redox state of Ero1p in vivo, wild-type or ero1-1 cells containing ERO1 plasmids were grown to exponential phase, treated with trichloroacetic acid (TCA) and NEM to block free thiols, and Ero1p was detected by western blotting after nonreducing SDS-PAGE (Figure 4 ). Due to the small size of NEM, the migration rate of Ero1p reflected formation or reduction of regulatory disulfide bonds only, as indicated by migration of Ero1p as a single band under reducing conditions. Under normal ER redox conditions (wild-type cells), Ero1p was predominantly oxidized (Figure 4 , lanes 1 and 2), suggesting that most cellular Ero1p is catalytically inactive and implying that a low level of Ero1p activity is sufficient to support protein oxidation. Under more reducing ER conditions, a dramatic shift in Ero1p mobility to reduced species was observed (Figure 4 , lane 6). Ero1p mutants lacking Cys90-Cys349 or Cys150-Cys295 comigrated with the reduced forms of Ero1p, although it was not clear what accounts for the precise disulfide connectivity of red1 and red2 (Figure 4) . Expression of functional Ero1p in the ero1-1 strain background resulted in a compact oxidized Ero1p band similar to that observed in wild-type cells (Figure 4 , lane 5 versus 1).
Overexpression of Ero1p-C150A-C295A Inhibits Cell Growth Overexpression of wild-type Ero1p results in increased oxidized glutathione production and confers resistance to DTT yet does not appear to be a major source of oxidative stress to cells (Cuozzo and Kaiser, 1999; Frand and Kaiser, 1998) . Our in vitro and in vivo studies indicated that under oxidizing conditions wild-type Ero1p was inactivated, which might prevent detrimental hyperoxidation of the ER. To test the effect of partially deregulated Ero1p mutants on cell function, we overexpressed Ero1p mutants unable to form the Cys90-Cys349 or Cys150-Cys295 disulfides. Overexpression of Ero1p-C150A-C295A caused a marked growth inhibition ( Figure 5A ), whereas strains overexpressing wild-type Ero1p, Ero1p-C90A-C349A, or Ero1p-C143A-C166A grew as well as a control strain containing empty vector ( Figure 5 and data not shown). Overexpression of Ero1p lacking both Cys90-Cys349 and Cys150-Cys295 resulted in a growth defect less pronounced than that observed with the Cys150-Cys295 mutant alone (data not shown). Based on the insolubility of this quadruple mutant expressed in E. coli, the decreased toxicity in yeast cells may reflect a decreased specific activity due to folding defects.
To follow the viability of cells after extended (4, 8, or 12 hr) overexpression of wild-type or mutant Ero1p, equivalent OD 600 units of cells were assayed for viable colonies by plating on glucose medium. A dramatic decrease in the number of viable cells was observed beginning 8 hr postinduction of Ero1p-C150A-C295A ( Figure 5D ). The viability of cells expressing Ero1p or Ero1p-C90A-C349A was also moderately decreased, which may reflect some toxicity from Ero1p and Ero1p-C90A-C349A activity or toxicity from an increased protein load in the ER due to Ero1p overexpression ( Figure 5D ).
The slow growth caused by Ero1p-C150A-C295A overexpression was more pronounced in an ire1D mutant strain, which is not able to induce the unfolded protein response (UPR), suggesting that the UPR may help alleviate the negative impact of Ero1p-C150A-C295A ( Figure 5B ). Ero1p-C150A-C295A overexpression elicits a modest induction of the UPR; 6 hr post Ero1p-C150A-C295A induction in a wild-type (IRE1 + ) strain, a 2-fold induction of the UPR (relative to cells with empty vector) was detected by using an UPRE-lacZ reporter. As a point of reference, a wild-type strain exposed to tunicamycin (5 mg/ml) for 6 hr caused a 10-fold induction of the UPR (data not shown). Overexpression of an Ero1p mutant lacking both Cys150-Cys295 and the shuttle cysteines (Cys100 and Cys105) was not detrimental to cell growth ( Figure 5C ). This result shows that the negative effect on growth depends on Ero1p catalytic activity. The absence of a growth defect with Ero1p-C100A-C105A-C150A-C295A also demonstrates that Ero1p-C150A-C295A uses the same catalytic cycle previously characterized for wild-type Ero1p (Frand and Kaiser, 2000; Sevier and Kaiser, 2006) .
Overexpressed Ero1p-C150A-C295A Is in a Reduced, Activated State To determine the redox state of overexpressed Ero1p, cells were harvested 5 hr after induction, treated with TCA and AMS to preserve thiol connectivity, and the overexpressed form of Ero1p was detected by immunoblotting for the myc-epitope after nonreducing SDS-PAGE (Figure 5E ). Ero1p, Ero1p-C90A-C349A, and Ero1p-C150A-C295A migrated at different rates under nonreducing conditions, reflecting differences in disulfide connectivity ( Figure 5E, lanes 1-3) . When cell extracts were treated with DTT (to reduce all disulfides) prior to AMS, Ero1p and Ero1p-C90A-C349A shifted to a slower-migrating form, indicating that both proteins contained at least one regulatory disulfide ( Figure 5E , lanes 1 and 2 versus lanes 4 and 5). The mobility of Ero1p-C150A-C295A did not significantly change upon DTT treatment, suggesting that the only regulatory disulfide in this mutant (Cys90-Cys349) was reduced prior to DTT addition ( Figure 5E , lane 3 versus lane 6). After DTT treatment, Ero1p migrated as a doublet ( Figure 5E ), which may reflect partial reduction of a short-range disulfide.
The different growth phenotypes observed after Ero1p-C90A-C349A and Ero1p-C150A-C295A overexpression can be explained by the redox state of the regulatory disulfides in these mutants. For Ero1p-C150A-C295A, Cys90-Cys349 appears to be reduced, consistent with enhanced catalytic activity, hyperoxidation of the ER, and cellular toxicity (Figures 3 and 5) . In contrast, for Ero1p-C90A-C349A, the single regulatory Cys150-Cys295 disulfide remains oxidized, thus inactivating Ero1p and preventing hyperoxidation of the ER ( Figure 5 ). For wild-type Ero1p, both Cys90-Cys349 and Cys150-Cys295 are oxidized, and overproduced Ero1p appears inactive ( Figure 5 ). The correlation between overexpression-induced toxicity and the absence of both regulatory disulfides suggests that reduction or loss of an individual regulatory disulfide is not sufficient for Ero1p activation.
Ero1p-C150A-C295A Exhibits Increased Activity In Vivo
To confirm that the growth defect from Ero1p-C150A-C295A overexpression was a consequence of increased Ero1p activity, we examined whether the negative effect of overexpression could be counteracted by a reducing agent. To prevent induction of UPR target genes upon exposure to reducing agent, these experiments were done in an ire1D strain . Addition of reduced DTT to the growth medium upon Ero1p-C150A-C295A induction resulted in a growth rate similar to that observed with a strain overexpressing wild-type Ero1p ( Figure 6A ). Rescue was not observed when the equivalent concentration of oxidized DTT was added ( Figure 6A) . Notably, the optimal DTT concentration for rescue of the growth defect (0.5 mM) is toxic to cells not overexpressing Ero1p; the oxidative activity of wild-type or mutant Ero1p counteracts the toxicity caused by the reducing agent ( Figure 6B ). To more directly examine the impact of Ero1p-C150A-C295A overexpression on the ER redox environment, we followed the rate of glutathione oxidation in yeast cells overexpressing Ero1p or Ero1p-C150A-C295A. The ratio of oxidized to reduced glutathione is 30-to 100-fold greater in the ER than in the cytosol (Hwang et al., 1992) , suggesting that most oxidized glutathione detected in an assay of whole cells is located in the ER. We assayed oxidized glutathione (GSSG) production by pulsing cells with (D) After 5 hr in SMM Gal, with or without BSO, the oxidation state of Ero1p-C150A-C295A was followed by resolving AMS-modified cellular proteins on nonreducing SDS-PAGE and immunoblotting with anti-myc. Reduced Ero1p-C150A-C295A was prepared by adding DTT to cells prior to AMS. After 5 hr of BSO treatment, total cellular glutathione levels were $15% of untreated cells (data not shown). (E) The impact of Ero1p-C150A-C295A overexpression on cellular oxidized glutathione (GSSG) levels was determined by using a whole-cell assay to follow GSSG regeneration, after reduction of cellular GSSG by DTT. Glutathione levels were assayed in CKY263 cells containing empty vector, pAF112, or pCS452. Cellular GSSG:GSH ratios are plotted as a function of time after DTT removal. White-filled data points represent cellular GSSG:GSH ratios measured immediately prior to DTT treatment.
reduced DTT to lower GSSG levels and subsequently following the rate of GSSG regeneration after DTT removal. As anticipated from previous studies (Cuozzo and Kaiser, 1999) , overexpression of Ero1p slightly enhanced the rate of GSSG regeneration relative to a strain containing empty vector ( Figure 6E ). However, overexpressing Ero1p-C150A-C295A substantially increased the rate of GSSG regeneration ( Figure 6E) . Notably, the initial GSSG:GSH ratio prior to DTT treatment was also shifted toward the more oxidized state in a strain overexpressing Ero1p-C150A-C295A ( Figure 6E ). These data confirm that overexpression of the hyperactive Ero1p shifts the ER redox environment to a more oxidizing state.
Surprisingly, lowering cellular glutathione levels by treatment with the GSH1 inhibitor buthionine sulfoxide (BSO) alleviated the growth defect from Ero1p-C150A-C295A overexpression ( Figure 6C ). As glutathione has been shown to buffer against hyperoxidizing conditions (Cuozzo and Kaiser, 1999) , it was initially expected that lowering glutathione levels would exacerbate the growth defect. Examination of the redox state of Ero1p-C150A-C295A in cells treated with BSO revealed a shift in Ero1p-C150A-C295A mobility to the oxidized, inactive species ( Figure 6D ). We suggest that inactivation of the hyperactive Ero1p mutant when glutathione is depleted prevents hyperoxidation of the ER, which outweighs the potential negative impact of diminished redox buffer. These data suggest that glutathione normally has a role in reducing and activating Ero1p. The fact that Ero1p-C150A-C295A can be inactivated by oxidation of Cys90-Cys349 confirms that both regulatory disulfides must be reduced to activate Ero1p.
DISCUSSION
We have demonstrated that two cysteine pairs in Ero1p, Cys90-Cys349 and Cys150-Cys295, affect Ero1p activity in a redox-dependent manner. When these cysteines are in the thiol (reduced) form, Ero1p is catalytically active; when they are in the disulfide (oxidized) form, Ero1p is inactive ( Figure 7B ). Our data suggest that posttranslational regulation of Ero1p activity governs the flow of oxidizing equivalents to the ER thiol pool, allowing the cell to maintain ER redox conditions favorable for native disulfide formation.
Homeostatic Control of Disulfide-Bond Formation
We propose that Ero1p regulation is part of a feedback circuit wherein changes in the ER redox environment are offset by modulation of Ero1p activity. If the ER becomes too oxidizing, the regulatory cysteine pairs of Ero1p become disulfide bonded, decreasing Ero1p activity and lessening the flow of oxidizing equivalents to protein thiols in the ER. Conversely, if the concentration of free thiols in the ER rises, the Ero1p regulatory disulfides are reduced, increasing enzyme activity and promoting disulfide-bond formation. The elegant simplicity of this system is the competition between dithiol substrates and the Ero1p regulatory dicysteine motifs themselves for Ero1p activity. Sufficient substrate availability maintains Ero1p in a reduced functional state. In the absence of substrates, Ero1p may catalyze oxidation of its own regulatory disulfides, effecting its own inactivation either in cis or in trans. This homeostatic system would be expected to buffer against fluctuations in the concentrations of thiol species in the ER as well as to dampen any effects of nonoptimal levels of Ero1p.
We observed a marked decrease in growth and viability of cells overexpressing an Ero1p mutant lacking one of the regulatory disulfides, Ero1p-C150A-C295A. Although the possibility that this mutant has some neomorphic hyperactive oxidative properties beyond those observed with reduced wild-type Ero1p cannot be excluded, we suggest that the toxic effects from Ero1p-C150A-C295A overexpression are the direct result of the mutant mimicking the activated state of Ero1p and constitutive hyperactive catalytic function (Figures 5 and 6) . Toxicity is likely a result of reactive oxygen species (ROS) accumulated during continual cycles of Ero1p oxidation and reduction, during which oxygen is consumed and hydrogen peroxide is produced. Tight control of Ero1p activity may minimize ROS production, especially under relatively oxidizing conditions when less reduced glutathione may be available to scavenge peroxide species.
Candidate redox-active species in the ER that may regulate Ero1p activity include reduced Pdi1p, Pdi1p homologs, and glutathione. Although reduced glutathione is a poor substrate of Ero1p Tu et al., 2000) and does not directly activate Ero1p in vitro (data not shown), cellular glutathione levels do influence the redox status and catalytic activity of Ero1p. Depleting cellular glutathione by blocking glutathione synthesis resulted in the oxidation of Ero1p-C150A-C295A, which was otherwise in the reduced state ( Figure 6D) . A potential explanation for the impact of glutathione on the redox state of Ero1p-C150A-C295A is that low glutathione levels may fail to reduce Pdi1p and/or related ER proteins, preventing them from activating Ero1p.
Mechanisms for Maintaining Redox Balance in Eukaryotes versus Bacteria
Oxidative protein folding in bacteria occurs in the periplasmic space, where disulfide formation is catalyzed by the transmembrane protein DsbB and the soluble periplasmic protein DsbA (reviewed by Kadokura et al. [2003] ). Also present in the bacterial periplasm are the transmembrane protein DsbD and its soluble partner DsbC, which constitute a pathway for reduction or isomerization of mispaired cysteines (reviewed in Messens and Collet [2006] and Porat et al. [2004] ). A major question in the study of oxidative protein folding in bacteria was how the oxidation and reduction pathways are kinetically isolated from one another such that the two competing pathways can operate simultaneously in the same compartment (Rozhkova et al., 2004) . The answer appears to be structural: steric incompatibility between the soluble component of one pathway and the membrane-embedded component of the opposing pathway (Bader et al., 2001; Inaba et al., 2006; Segatori et al., 2006) .
In eukaryotes, the oxidation and reduction pathways appear not to utilize different oxidoreductases but rather to converge on Pdi1p. The redox state of Pdi1p, and consequently its function, may be tuned by regulating Ero1p activity. Accumulation of more Pdi1p in the reduced state when Ero1p activity is compromised may increase the amount of Pdi1p available to act as a reductase or isomerase (Frand and Kaiser, 1999) . Favoring reduced Pdi1p may be advantageous under hyperoxidizing conditions to promote the reshuffling of nonnative disulfide bonds accumulated during oxidative stress. The enhanced chaperone activity of reduced Pdi1p may also stimulate the unfolding, dislocation and degradation of misfolded ER proteins (Tsai et al., 2001) . Using feedback regulation of Ero1p to tightly control the redox state of Pdi1p solves the challenge of simultaneously maintaining oxidized and reduced pools of oxidoreductase in the ER, providing a solution distinct from the kinetically isolated pathways of the bacterial periplasm.
Structural Basis for Ero1p Redox Regulation
The availability of a crystal structure of Ero1p allows us to speculate on the mechanism by which the regulatory disulfides influence Ero1p catalytic activity. It has been suggested previously that movement of the region containing the catalytic shuttle cysteines facilitates electron transfer from Pdi1p to the Ero1p active site (Gross et al., 2004) . Intriguingly, the Cys90-Cys349 and Cys150-Cys295 disulfides connect the nonhelical cap, in which the shuttle cysteines are located, with the helical core of Ero1p (Figure 1 ; Gross et al., 2004) . By tethering the loops of the cap to the protein core, the regulatory disulfides may restrict loop mobility, thus decreasing Ero1p activity (Figure 7) .
We suggest that phenotypic differences between the Ero1p-C90A-C349A and Ero1p-C150A-C295A mutants do not indicate a greater importance for Cys150-Cys295 in the control Ero1p activity but rather reflect interdependence of the two cysteine pairs. Differences in Ero1p activation and catalytic function observed with these alleles can be explained by three considerations: (1) Ero1p is fully active only when both regulatory bonds are reduced, (2) the Cys90-Cys349 bond is unstable when the Cys150-Cys295 bond is absent, and (3) the stability of the Cys150-Cys295 bond is not significantly influenced by Cys90-Cys349. Accordingly, for the Ero1p-C150A-C295A mutant, Cys90-Cys349 is easily reduced and the mutant is constitutively active, whereas the Ero1p-C90A-C349A mutant still displays redox-dependent feedback inhibition due to oxidation of Cys150-Cys295.
Putative Regulatory Disulfides in Ero1p Orthologs
The presence in Ero1p homologs of multiple cysteine residues in addition to those directly involved in catalysis suggests the potential for redox regulation of Ero1 proteins in multicellular organisms. A Cys90-Cys349 equivalent is found in all but one of the Ero1p homologs (Encephalitozoon cuniculi) and likely forms a conserved regulatory disulfide. In contrast, the Ero1p Cys150-Cys295 disulfide is less conserved. Most fungal homologs share a positionally conserved Cys150-Cys295 pair, yet Ero1 proteins from multicellular eukaryotes appear to lack a Cys150-Cys295 equivalent. Perhaps Cys150-Cys295 evolved as a regulatory disulfide uniquely suited to respond to changes in the ER environment of fungi. Alternatively, the regulatory function of Cys150-Cys295 could be accomplished in other organisms by a disulfide in a different position. Ero1 proteins from multicellular eukaryotes contain an additional cysteine residue four residues downstream of the second shuttle cysteine, which has the potential to form a disulfide bond with the helical core region. Human Ero1-La migrates on nonreducing gels as three distinct redox isoforms (R, Ox1, and Ox2) (Benham et al., 2000) . In agreement with the potential for two long-range loop-to-core disulfides in Ero1-La, it has been speculated that the Ox1 isoform reflects the formation of a Cys90-Cys349 equivalent disulfide (Cys85-Cys391) and Ox2 reflects the formation of both Cys85-Cys391 and an additional disulfide bond (Bertoli et al., 2004) .
Regulation of Ero1 activity in higher eukaryotes could play an important role during cell growth and differentiation. For example, increased thiol content as a consequence of enhanced secretory capacity could activate Ero1 and help facilitate IgM subunit assembly during plasma cell differentiation. Development of assays similar to those described herein for yeast Ero1p should enable the study of mammalian Ero1 regulation. Further investigations making use of these new tools in both yeast and human cells should identify the intracellular signals that regulate Ero1 activity and eukaryotic disulfide bond formation.
EXPERIMENTAL PROCEDURES
Saccharomyces cerevisiae strains were grown and genetically manipulated by using standard techniques (Adams et al., 1998) . SMM, SMM Gal, and SMM Raf are synthetic minimal media containing 2% glucose, galactose, or raffinose. Uracil or leucine media supplements were removed to select for plasmids as needed. Frand and Kaiser (1998) and Sevier and Kaiser (2006) . Plasmid pAF112 is pAF82 with a GAL1 promoter in place of the 5 0 ERO1
Strains and Plasmid Construction
UTR (Frand and Kaiser, 1998) . To create CEN URA3 ERO1-myc plas-
, and pCS524 [ero1-C150A-C295A], amino acid replacements were made in pAF82, pAF112, or pAF85 by QuikChange site-directed mutagenesis (Stratagene) or by subcloning mutations from previously constructed ERO1 plasmids using standard techniques.
Plasmids encoding glutathione S-transferase (GST) fused to a His 6 -tagged Ero1p (residues 56-424; Ero1p-c), GST-tagged Ero1p (residues 10-424), and His 6 -tagged thioredoxin (Trx1) or Pdi1p have been described (Gross et al., 2004 (Gross et al., , 2006 Sevier et al., 2001 ). Ero1p-c mutant plasmids pCS410 [ero1-c-C90A-C349A] and pCS425 [ero1-c-C150A-C295A] were constructed by mutagenesis.
CKY598 (ero1-1) and CKY933 (ero1D [pAF82]) strains are described in Frand and Kaiser (1998) and Sevier and Kaiser (2006) . CKY1026 (ire1D) was made by one-step gene replacement of IRE1 with KanMX in CKY263 112) . CKY1027, CKY1028, CKY1029, and CKY1030 strains were generated by transformation of CKY933 with pAF85, pCS430, pCS523, or pCS524, followed by selection against pAF82 by plating on SMM with 5-fluoroorotic acid (5-FOA; Toronto Research Laboratories, Downsview, Ontario, Canada).
Expression and Purification of Ero1p, Trx1, and Pdi1p GST-tagged Ero1p (residues 10-424) was purified as described (Gross et al., 2006) . Ero1p-c, Trx1, and Pdi1p were expressed and purified essentially as described (Sevier et al., 2001; Sevier and Kaiser, 2006) .
Oxygen Consumption and Ero1p Oxidation State In Vitro
Reduced Trx1 was prepared by incubation of purified Trx1 with 50 mM DTT for 1 hr at room temperature. Trx1 and DTT were separated by using a PD-10 column equilibrated in buffer A (50 mM potassium phosphate [pH 7.5], 65 mM NaCl, and 0.5 mM EDTA). Column fractions containing reduced Trx1 were pooled, and the concentration of reduced Trx1 was calculated with Ellman's reagent.
Oxygen consumption was measured in a 1.0 ml volume by using an Oxygraph Clark-type oxygen electrode (Hansatech Instruments). Reduced Trx1 was diluted to 100 mM in buffer A, and oxygen levels were monitored until a linear baseline was established, at which time the reaction was initiated by injection of 50 ml of 10 mM Ero1p-c (0.5 mM final). For reactions with Pdi1p, Pdi1p was diluted to 100 mM in buffer A with 10 mM GSH, and Ero1p-c was added to a final concentration of 2 mM. To determine the oxidation states of Ero1p-c and Trx1 during their reaction, 10 ml samples were removed and immediately mixed with an equal volume of 2X sample buffer (160 mM Tris-HCl [pH 6.8], 20% glycerol, 4% SDS, and bromphenol blue) containing 2 mM AMS (Molecular Probes). The samples were incubated at room temperature for 30 min prior to electrophoresis on a 15% SDS-polyacrylamide gel. To detect Trx1, the gel was stained with Coomassie blue or transferred to nitrocellulose and stained with Ponceau S. To detect Ero1p-c, the gel was transferred to nitrocellulose and probed with anti-Ero1 serum. Antiserum to Ero1p was obtained by injection of Ero1p-c protein into rabbits by Covance, Inc. (Denver, PA).
To prepare trypsin-cleaved Ero1p-c, 30 mM Ero1p-c was incubated with 12.5 mg/ml trypsin (Sigma) in 10 mM Tris-HCl (pH 8.5), 25 mM NaCl for 1 hr at room temperature followed by addition of 1:100 v/v phenylmethylsulphonylfluoride in isopropanol. Reaction with Trx1 (50 mM) was conducted with 5 mM cleaved Ero1p-c to facilitate visualization of enzyme fragments and 1 mM DTT (a poor substrate for the enzyme but a rapid reductant of oxidized Trx1) to retain the 1:200 enzyme:substrate ratio and extend the reaction time. The trypsin cleavage site in Ero1p-c was determined by N-terminal peptide sequencing of the $30 kDa fragment blotted from a reducing gel onto polyvinylidene fluoride membrane.
To follow the rate of inactivation of Ero1p, the longer Ero1p construct (residues 10-424) was used. Enzyme was injected to a 0.5 mM final concentration into the oxygen electrode reaction chamber containing 50 mM reduced Trx1 in buffer A. At the indicated times following Ero1p injection, 40 ml of a 1.34 mM reduced Trx1 solution was injected. The second oxygen consumption curves were scaled between 1 and 0 and superposed from the time of the second injection.
Growth Curves CKY263 or CKY1026 cells containing P GAL1 -ERO1-myc plasmids or empty vector were grown overnight at 30 C in SMM Raf, subcultured the following morning to an OD 600 of 0.2 in SMM Gal, and returned to 30 C. Drug treatments (0.5 mM DTT or 5.0 mM BSO) were added to the cultures at the time of subculturing. Cultures were sampled hourly for OD measurements at 600 nm.
CPY Radiolabeling and Immunoprecipitation CKY1027, CKY1028, CKY1029, or CKY1030 cells were grown to exponential phase, and cells were harvested and suspended at 5 OD 600 units/ml in SMM lacking methionine. Cells were labeled at 30 C for 7 min with [ 35 S]methionine and chased for 0 to 15 min with cold methionine. Cell lysis and immunoprecipitation of CPY were completed as described .
Oxidized Glutathione Regeneration CKY263 cells containing pAF112, pCS452, or vector were grown overnight at 30 C in SMM Raf and subcultured the following morning in the same medium to an OD 600 of 0.1. After 3.5 hr at 30 C, galactose (2% final) was added and the cells were returned to 30 C for 3 hr. Cultures were treated with 10 mM DTT for 15 min at 30 C to reduce intracellular GSSG. DTT was removed by filtering, and cells were suspended in fresh SMM Raf Gal. At various times after DTT removal, cells were collected by centrifugation and suspended in ice-cold 1% sulfosalicyclic acid to prevent further oxidation. Cells were lysed, and glutathione levels were measured as described (Cuozzo and Kaiser, 1999) . All strains showed similar increases in both OD 600 and total glutathione levels throughout the recovery period.
Assays for Ero1 Oxidation State CKY263 or CKY598 cells containing pAF82, pCS56, pCS481, or pCS483 were grown to exponential phase at 24 C or 30 C in SMM.
CKY1026 cells containing pAF112, pCS450, or pCS452 were subcultured from SMM Raf into SMM Gal to an OD 600 of 0.2 and were grown for 5 hr at 30 C. Cells were collected and suspended in 10% (w/v) TCA, lysed by agitation with glass beads, and proteins were collected by centrifugation at 4 C. For a subset of samples, protein pellets were resuspended in medium with 50 mM DTT for 15 min and proteins were reprecipitated with TCA. For a typical experiment, a protein pellet from 5 OD 600 units of cells was suspended in 50 ml of 1X sample buffer with 50 mM NEM and a protease inhibitor cocktail (Roche), and the pH of the samples was adjusted by gradual addition of 1 M Tris-HCl (pH 8.0) until samples turned blue. Samples were incubated on ice for 30 min and boiled for 2 min. The pH of the samples was lowered by addition of sodium citrate (pH 5.5) to a final concentration of 67 mM, and samples were treated with 250 units endoglycosidase H (NEB) for 60 min at 37 C. Insoluble material was removed by centrifugation, samples were resolved by nonreducing SDS-PAGE and transferred to nitrocellulose, and Ero1p was detected with anti-myc (9E10).
